Showing results (491-500 of 601) with videos related to

Sort By:
Pageof 61
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|April 11, 2017
Genetic study of neuregulin 1 and receptor tyrosine-protein kinase erbB-4 in tardive dyskinesiaClement C Zai, Arun K Tiwari, Nabilah I Chowdhury, et al.
Clinical Pharmacology and Therapeutics|January 29, 2024
CYP2D6 Phenotype Influences Pharmacokinetic Parameters of Venlafaxine: Results from a Population Pharmacokinetic Model in Older Adults with DepressionXiaoyu Men, Zachary L Taylor, Victoria S Marshe, et al.
Psychiatry Research|July 31, 2023
Response trajectories during escitalopram treatment of patients with major depressive disorderJohn-Jose Nunez, Yang S Liu, Bo Cao, et al.
Neuroscience Letters|April 13, 2005
The SNAP-25 gene may be associated with clinical response and weight gain in antipsychotic treatment of schizophreniaDaniel J Müller, Tim A Klempan, Vincenzo De Luca, et al.
Psychiatry Research|August 24, 2015
Physicians' opinions following pharmacogenetic testing for psychotropic medicationLucas M Walden, Eva J Brandl, Amtul Changasi, et al.
Schizophrenia Research|July 21, 2026
Pharmacogenomics of antipsychotic-induced weight gain: A systematic reviewMartin Kronenbuerger, Kazunari Yoshida, Pei Yuan Li, et al.
Schizophrenia Research|October 8, 2008
Genetic study of eight AKT1 gene polymorphisms and their interaction with DRD2 gene polymorphisms in tardive dyskinesiaClement C Zai, Marco A Romano-Silva, Rudi Hwang, et al.
Psychological Medicine|December 29, 2025
Which aspects of anhedonia predict response to pharmacotherapy in major depressive disorder?Rudolf Uher, Sakina J Rizvi, Lena C Quilty, et al.
Pageof 61